The objective of the present study is to investigate key aspects of ovarian and breast cancers, which are two main causes of mortality among women. Identification of the true behavior of survivorship and influential risk factors is essential in designing treatment protocols, increasing disease awareness and preventing possible causes of disease. There is a commonly held belief that African Americans have a higher risk of cancer mortality. We studied racial disparities of women diagnosed with ovarian cancer on overall and disease-free survival and found out that there is no significant difference in the survival experience among the three races: Whites, African Americans and Other races. Tumor sizes at diagnosis among...
BACKGROUND: Although rates of survival for women with breast cancer have improved, the survival disp...
Ovarian cancer is the leading cause of death from gynecologic malignancies among women worldwide. Li...
Ovarian cancer is the leading cause of death from gynecologic malignancies among women worldwide. Li...
The objective of the present study is to investigate key aspects of ovarian and breast cancers, ...
In this study we used the parametric survival approach to analyze the survival time of African Ameri...
In this study we used the parametric survival approach to analyze the survival time of African Ameri...
In this study we used the parametric survival approach to analyze the survival time of African Ameri...
ObjectiveAlthough ovarian cancer is a deadly disease, approximately a third of women survive ≥9 ...
BACKGROUNDOvarian cancer is the fifth leading cause of cancer death among women in the United States...
Cancer ranks as a leading cause of death worldwide; an estimated 1.7 million new diagnoses were repo...
Breast, endometrial, and ovarian cancers share some hormonal and epidemiologic risk factors. While s...
Breast, endometrial, and ovarian cancers share some hormonal and epidemiologic risk factors. While s...
Ovarian cancer is the deadliest gynecologic cancer, with a five-year survival of only 47%. Treatment...
Ovarian cancer is the deadliest gynecologic cancer, with a five-year survival of only 47%. Treatment...
Background: Breast cancer is the second leading cause of cancer death for women in the United States...
BACKGROUND: Although rates of survival for women with breast cancer have improved, the survival disp...
Ovarian cancer is the leading cause of death from gynecologic malignancies among women worldwide. Li...
Ovarian cancer is the leading cause of death from gynecologic malignancies among women worldwide. Li...
The objective of the present study is to investigate key aspects of ovarian and breast cancers, ...
In this study we used the parametric survival approach to analyze the survival time of African Ameri...
In this study we used the parametric survival approach to analyze the survival time of African Ameri...
In this study we used the parametric survival approach to analyze the survival time of African Ameri...
ObjectiveAlthough ovarian cancer is a deadly disease, approximately a third of women survive ≥9 ...
BACKGROUNDOvarian cancer is the fifth leading cause of cancer death among women in the United States...
Cancer ranks as a leading cause of death worldwide; an estimated 1.7 million new diagnoses were repo...
Breast, endometrial, and ovarian cancers share some hormonal and epidemiologic risk factors. While s...
Breast, endometrial, and ovarian cancers share some hormonal and epidemiologic risk factors. While s...
Ovarian cancer is the deadliest gynecologic cancer, with a five-year survival of only 47%. Treatment...
Ovarian cancer is the deadliest gynecologic cancer, with a five-year survival of only 47%. Treatment...
Background: Breast cancer is the second leading cause of cancer death for women in the United States...
BACKGROUND: Although rates of survival for women with breast cancer have improved, the survival disp...
Ovarian cancer is the leading cause of death from gynecologic malignancies among women worldwide. Li...
Ovarian cancer is the leading cause of death from gynecologic malignancies among women worldwide. Li...